A Study to Assess Etoricoxib Versus Diclofenac in Chinese Patients With Osteoarthritis of the Knee or Hip (0663-080)(COMPLETED)

Phase 4

Completed

• Conditions: Osteoarthritis

• Registration Number: NCT00140972
• Lead Sponsor: Organon and Co

Brief Summary

A Study to Assess Etoricoxib versus Diclofenac in Chinese Patients with Osteoarthritis of the Knee or Hip

Detailed Description

Not available

Study Timeline

• Study Start: 2004-12-03
• Primary Completion: 2005-06-27
• Study Completion: 2005-06-27
• Study First Submitted: 2005-08-30
• Study First Submitted QC: 2005-08-30
• Study First Posted: 2005-09-01
• Status Verified: 2022-02
• Last Update Submitted: 2024-08-12
• Last Update Posted: 2024-08-15

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 160

Inclusion Criteria

• Chinese males or females at least 40 years of age with osteoarthritis of the knee or hip

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
WOMAC pain subscale

Secondary Outcome Measures

Name	Time	Method
WOMAC Physical function subscale; WOMAC Stiffness subscale; Patient Global Assessment of Response to Therapy; Investigator Global Assessment of Disease Status